These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 29709351)
1. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma. Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351 [TBL] [Abstract][Full Text] [Related]
2. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768 [TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
4. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer. Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339 [TBL] [Abstract][Full Text] [Related]
5. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955 [TBL] [Abstract][Full Text] [Related]
6. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder. Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645 [TBL] [Abstract][Full Text] [Related]
8. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance. Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma. Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792 [TBL] [Abstract][Full Text] [Related]
10. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma. Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871 [TBL] [Abstract][Full Text] [Related]
11. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
12. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Ahn S; Hyeon J; Park CK Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774 [TBL] [Abstract][Full Text] [Related]
13. Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas. Li S; Liu Y; Shen Z Hepatogastroenterology; 2012 Oct; 59(119):2054-8. PubMed ID: 22640914 [TBL] [Abstract][Full Text] [Related]
14. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma. Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma. Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602 [TBL] [Abstract][Full Text] [Related]
17. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma. Fatourou E; Koskinas J; Karandrea D; Palaiologou M; Syminelaki T; Karanikolas M; Felekouras E; Antoniou E; Manesis EK; Delladetsima J; Tiniakos D Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1094-102. PubMed ID: 26011233 [TBL] [Abstract][Full Text] [Related]
18. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma. Zhang D; Ma X; Sun W; Cui P; Lu Z Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876 [TBL] [Abstract][Full Text] [Related]
19. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813 [TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma. Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]